Merck v. Integra: § 271(e)(1) and the Common Law Research Exemption.
- Published in:
- Journal of Corporation Law, 2007, v. 32, n. 4, p. 943
- By:
- Publication type:
- Article
Works matching Merck
Results: 5000
1
2
Flexibility implementation to a global workforce: a case study of Merck and Company, Inc.
- Published in:
- Community, Work & Family, 2011, v. 14, n. 2, p. 249, doi. 10.1080/13668803.2011.571404
- By:
- Publication type:
- Article
3
The Patent Research Tool Problem After Merck v. Integra.
- Published in:
- Texas Intellectual Property Law Journal, 2005, v. 14, n. 1, p. 1
- By:
- Publication type:
- Article
4
Deviations and Conversions, Seventies Style: Mandy Merck in Conversation with Laura Guy.
- Published in:
- Third Text, 2021, v. 35, n. 1, p. 11, doi. 10.1080/09528822.2020.1864975
- By:
- Publication type:
- Article
5
Merck v. Integra: Bailing Water Without Plugging the Hole.
- Published in:
- BYU Journal of Public Law, 2006, v. 20, n. 2, p. 579
- By:
- Publication type:
- Article
6
INTEGRA LIFESCIENCES I, LTD. V. MERCK KGAA: RE-EXAMINING THE BROAD SCOPE OF THE § 271(E)(1) SAFE HARBOR.
- Published in:
- Berkeley Technology Law Journal, 2008, v. 23, n. 1, p. 107
- By:
- Publication type:
- Article
7
Boston University School of Law Merck KGaA v. Integra Lifesciences I, Ltd: Implications of the Supreme Court's Decision for the People Who Matter Most… the Consumer.
- Published in:
- American Journal of Law & Medicine, 2007, v. 33, n. 1, p. 97, doi. 10.1177/009885880703300103
- By:
- Publication type:
- Article
8
Eine „Schandgasse" im Arbeitskampf: Der Chemiestreik 1971 bei Merck in Darmstadt – eine Fallstudie zu den industriel-len Beziehungen in der Bundesrepublik am Ende des „Wirtschaftswunders".
- Published in:
- Vierteljahrshefte für Zeitgeschichte, 2020, v. 68, n. 3, p. 409, doi. 10.1515/vfzg-2020-0026
- By:
- Publication type:
- Article
9
An Early Collection of the Red Alga Mikamiella ruprechtiana Made by Carl Merck on the Billing Expedition to Alaska (1785-94).
- Published in:
- Arctic Journal, 2006, v. 59, n. 4, p. 365
- By:
- Publication type:
- Article
10
Reconstructing Merck's Practical Theory of Communication: The Ethics of Pharmaceutical Sales Representative-Physician Encounters.
- Published in:
- Communication Monographs, 2011, v. 78, n. 1, p. 53, doi. 10.1080/03637751.2010.542578
- By:
- Publication type:
- Article
11
Merck and Vioxx: An Examination of an Ethical Decision-Making Model.
- Published in:
- Journal of Business Ethics, 2007, v. 76, n. 4, p. 451, doi. 10.1007/s10551-006-9302-3
- By:
- Publication type:
- Article
12
Revivals of an Ancient Myth in Modern Art: Oedipus and the Episode of the Sphinx. From Jean Auguste-Domenique Ingres to Michael Merck.
- Published in:
- Trends in Classics, 2011, v. 3, n. 1, p. 154, doi. 10.1515/tcs.2011.008
- By:
- Publication type:
- Article
13
"Putting Patients First": Systematically Distorted Communication and Merck's Marketing of Vioxx.
- Published in:
- Journal of Applied Communication Research, 2007, v. 35, n. 4, p. 376, doi. 10.1080/00909880701611052
- By:
- Publication type:
- Article
14
Open conflict on the handling of the Merck drug Vioxx by editorial giants.
- Published in:
- Reproductive BioMedicine Online (Reproductive Healthcare Limited), 2006, v. 13, n. 6, p. 905, doi. 10.1016/S1472-6483(10)61040-1
- By:
- Publication type:
- Article
15
Preserving biodiversity in Costa Rica: the case of the Merck-INBio Agreement
- Published in:
- Journal of Environment & Development, 1997, v. 6, n. 2, p. 180, doi. 10.1177/107049659700600206
- By:
- Publication type:
- Article
16
Revitalizing portfolio decision-making at Merck Serono S.A. - Geneva.
- Published in:
- Journal of Commercial Biotechnology, 2011, v. 17, n. 1, p. 24, doi. 10.1057/jcb.2010.26
- By:
- Publication type:
- Article
17
األدلح الشة اللغوية في كتاب شرمائل المحمديازية لميرك شاه الشير (ت بعد930هـ).
- Published in:
- Journal of Anbar University for Languages & Literature / Magallat Gami'at Al-Anbar Li-Lugat Wa-al-Adabl, 2022, n. 36, p. 351
- By:
- Publication type:
- Article
18
Bilanz Merck 2023: Mehr Medikamente, weniger Elektronik.
- Published in:
- Nachrichten aus der Chemie, 2024, v. 72, n. 4, p. 40, doi. 10.1002/nadc.20244140760
- By:
- Publication type:
- Article
19
Bilanz Merck 2022: Medikamente und Halbleiterprodukte.
- Published in:
- Nachrichten aus der Chemie, 2023, v. 71, n. 4, p. 46, doi. 10.1002/nadc.20234135236
- By:
- Publication type:
- Article
20
Merck: Forschung, Pharma und Halbleiter.
- Published in:
- Nachrichten aus der Chemie, 2022, v. 70, n. 5, p. 50, doi. 10.1002/nadc.20224124097
- Publication type:
- Article
21
Merck announces new name for its Animal Health Division.
- Published in:
- Canadian Veterinary Journal / Revue Vétérinaire Canadienne, 2011, v. 52, n. 11, p. 1256
- Publication type:
- Article
22
Merck Helps/Merck Access Program.
- Published in:
- Oncology Practice Management, 2019, p. 80
- Publication type:
- Article
23
Das wissenschaftliche Unternehmen: Zur chemisch-pharmazeutischen Forschung bei E. Merck, Darmstadt, ca. 1900 bis 1930.
- Published in:
- Zeitschrift für Unternehmensgeschichte, 2017, v. 62, n. 2, p. 163, doi. 10.1515/zug-2017-1003
- By:
- Publication type:
- Article
24
Caskey to head Merck's genome efforts.
- Published in:
- Nature, 1994, v. 371, n. 6500, p. 731, doi. 10.1038/371731c0
- By:
- Publication type:
- Article
25
Merck to back `public' sequencing.
- Published in:
- Nature, 1994, v. 371, n. 6496, p. 365, doi. 10.1038/371365b0
- By:
- Publication type:
- Article
26
Bilanz 2020: Merck.
- Published in:
- Nachrichten aus der Chemie, 2021, v. 69, n. 5, p. 55, doi. 10.1002/nadc.20214106999
- By:
- Publication type:
- Article
27
Bilanz Merck: für Forscher und Flüssigkristalle.
- Published in:
- Nachrichten aus der Chemie, 2017, v. 65, n. 4, p. 447, doi. 10.1002/nadc.20174061436
- By:
- Publication type:
- Article
28
Pharmaceutical Research in Wilhelmine Germany: The Case of E. Merck.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
29
Merck's Actions Surrounding Vioxx.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
30
Serono sold to Merck.
- Published in:
- Reproductive BioMedicine Online (Reproductive Healthcare Limited), 2006, v. 13, n. 5, p. 650
- Publication type:
- Article
31
Screening antibiotics: industrial research by CEPA and Merck in the 1950s.
- Published in:
- Dynamis, 2011, v. 31, n. 2, p. 407, doi. 10.4321/S0211-95362011000200008
- By:
- Publication type:
- Article
32
The evolution of drug design at Merck Research Laboratories.
- Published in:
- Journal of Computer-Aided Molecular Design, 2017, v. 31, n. 3, p. 255, doi. 10.1007/s10822-016-9993-1
- By:
- Publication type:
- Article
33
Merck strengthens drug pipeline in rival takeover.
- Published in:
- Nature, 2009, v. 458, n. 7235, p. 137, doi. 10.1038/458137a
- Publication type:
- Article
34
"Not Just for Doctors Anymore": How the Merck Manual Became a Consumer Health "Bible".
- Published in:
- Bulletin of the History of Medicine, 2021, v. 95, n. 1, p. N.PAG, doi. 10.1353/bhm.2021.0000
- By:
- Publication type:
- Article
35
Merck Drug Prevents Serious Infection After Marrow Transplant: Study.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 11, p. i, doi. 10.1093/cid/cix261
- By:
- Publication type:
- Article
36
Merck Hopes To Extend Gardasil Vaccine to Men.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 4, p. 222, doi. 10.1093/jnci/djp014
- By:
- Publication type:
- Article
37
The Aftermath of Merck: D&O Insecurity in the Security Fraud Arena.
- Published in:
- Pace Law Review, 2012, v. 32, n. 1, p. 217, doi. 10.58948/2331-3528.1798
- By:
- Publication type:
- Article
38
GSK and Merck to provide cheap cancer vaccine.
- Published in:
- TCE: The Chemical Engineer, 2013, n. 864, p. 16
- Publication type:
- Article
39
Merck and Dr. Reddy's form biosimilars team.
- Published in:
- TCE: The Chemical Engineer, 2012, n. 853, p. 6
- Publication type:
- Article
40
Merck and Schering-Plough to merge.
- Published in:
- TCE: The Chemical Engineer, 2009, n. 814, p. 5
- Publication type:
- Article
41
Merck to pay whistleblower.
- Published in:
- TCE: The Chemical Engineer, 2008, n. 801, p. 12
- Publication type:
- Article
42
MERCK.
- Published in:
- Allergy, 1998, v. 53, n. 5, p. 27
- Publication type:
- Article
43
Merck KgaA v. Integra Life Sciences: US Supreme Court clarifies scope of the safe harbor provision.
- Published in:
- Journal of Generic Medicines, 2005, v. 3, n. 1, p. 75, doi. 10.1057/palgrave.jgm.4940101
- Publication type:
- Article
44
Merck Manuals Information Online <http://www.merck.com/mmhe>.
- Published in:
- Journal of Consumer Health on the Internet, 2009, v. 13, n. 1, p. 66, doi. 10.1080/15398280802674883
- By:
- Publication type:
- Article
45
Merck's Informatics Mission.
- Published in:
- 2008
- Publication type:
- Interview
46
Merck's Informatics Mission.
- Published in:
- 2008
- Publication type:
- Interview
47
Merck President Touts Technology.
- Published in:
- Bio-IT World, 2006, v. 5, n. 2, p. 1
- By:
- Publication type:
- Article
48
Rosetta Takes Merck IT Reins.
- Published in:
- Bio-IT World, 2004, v. 3, n. 3, p. 22
- By:
- Publication type:
- Article
49
MERCK: WE'RE SO LATE WE'RE EARLY.
- Published in:
- Bio-IT World, 2003, v. 2, n. 11, p. 1
- By:
- Publication type:
- Article
50
Deal watch: Monoclonal antibodies targeting Clostridium difficile licensed to Merck.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 442, doi. 10.1038/nrd2911
- Publication type:
- Article